Analystreport

Aimmune Therapeutics Inc (NASDAQ: AIMT) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating on the stock.

AIMMUNE THERAPEUTICS  (AIMT) 
Last aimmune therapeutics earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.aimmune.com/corporate-profile